Collections
Gallery
Gallery

List View

Showing 1 - 24 of 24 Records

Title (A-Z) Title (Z-A) Date (Ascending) Date (Descending)
25 50 100
Miniature of Operation Warp Speed and the COVID-19 Vaccine
Operation Warp Speed and the COVID-19 Vaccine
  • GSB Authors: Kevin Schulman
  • Date: 2021-04-28
  • Publication Type: Cases
Miniature of Novartis' Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries' Health Care Systems
Novartis' Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries' Health Care Systems
  • GSB Authors: Robert Chess
  • Date: 2014-01-06
  • Publication Type: Cases
Miniature of Takeda Pharmaceutical Company (B), the Millennium Acquisition
Takeda Pharmaceutical Company (B), the Millennium Acquisition
  • GSB Authors: Charles O'Reilly
  • Date: 2012-05-08
  • Publication Type: Cases
Miniature of Takeda Pharmaceutical Company, Becoming a Global Company (A)
Takeda Pharmaceutical Company, Becoming a Global Company (A)
  • GSB Authors: Charles O'Reilly
  • Date: 2012-05-07
  • Publication Type: Cases
Miniature of Takeda Pharmaceutical Company (C), the Future of Takeda
Takeda Pharmaceutical Company (C), the Future of Takeda
  • GSB Authors: Charles O'Reilly
  • Date: 2012-03-06
  • Publication Type: Cases
Miniature of Wyeth Pharmaceuticals: Changing the Mindsets and Behaviors of 17,000 People... One Person at a Time
Wyeth Pharmaceuticals: Changing the Mindsets and Behaviors of 17,000 People... One Person at a Time
  • GSB Authors: Hayagreeva Rao | Robert Sutton
  • Date: 2009-10-01
  • Publication Type: Cases
Miniature of Compulsory Licensing, Thailand, and Abbott Laboratories
Compulsory Licensing, Thailand, and Abbott Laboratories
  • GSB Authors: David Baron
  • Date: 2008-10-20
  • Publication Type: Cases
Miniature of Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome
Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome
  • GSB Authors: David Baron
  • Date: 2008-10-20
  • Publication Type: Cases
Miniature of Molecular Insight Pharmaceuticals Integrated Strategy for a Development Stage Molecular Medicine Company
Molecular Insight Pharmaceuticals Integrated Strategy for a Development Stage Molecular Medicine Company
  • GSB Authors: David Baron
  • Date: 2008-05-05
  • Publication Type: Cases
Miniature of Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
  • GSB Authors: Robert Chess | Stefanos Zenios
  • Date: 2008-01-14
  • Publication Type: Cases
Miniature of Negotiating Partnerships in the Healthcare Industry (A): The Pharmac and Respire Deal
Negotiating Partnerships in the Healthcare Industry (A): The Pharmac and Respire Deal
  • GSB Authors: Robert Chess | Stefanos Zenios
  • Date: 2008-01-14
  • Publication Type: Cases
Miniature of Exubera and Nice
Exubera and Nice
  • GSB Authors: Robert Chess | Stefanos Zenios
  • Date: 2008-01-02
  • Publication Type: Cases
Miniature of Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations
Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations
  • GSB Authors: Harikesh Nair
  • Date: 2006-11-17
  • Publication Type: Working Papers
Miniature of Connetics and Relaxin
Connetics and Relaxin
  • GSB Authors: Robert Chess | Mark Leslie
  • Date: 2006-03-15
  • Publication Type: Cases
Miniature of Abbott Laboratories and Humira: Launching a Blockbuster Drug
Abbott Laboratories and Humira: Launching a Blockbuster Drug
  • GSB Authors: Robert Chess | Stefanos Zenios
  • Date: 2005-06-20
  • Publication Type: Cases
Miniature of Zeneca's Direct-To-Consumer Advertising of Nolvadex
Zeneca's Direct-To-Consumer Advertising of Nolvadex
  • GSB Authors: Margaret Eaton
  • Date: 2005-04-12
  • Publication Type: Cases
Miniature of Developing and Marketing a Blockbuster Drug: Lessons from Eli Lilly's Experience with Prozac
Developing and Marketing a Blockbuster Drug: Lessons from Eli Lilly's Experience with Prozac
  • GSB Authors: Margaret Eaton
  • Date: 2005-02-25
  • Publication Type: Cases
Miniature of Vaxgen, Inc., Fighting the Aids Epidemic
Vaxgen, Inc., Fighting the Aids Epidemic
  • GSB Authors: Margaret Eaton
  • Date: 2005-02-15
  • Publication Type: Cases
Miniature of Abbott Laboratories and Humira: Launching a Blockbuster Drug
Abbott Laboratories and Humira: Launching a Blockbuster Drug
  • GSB Authors: Robert Chess | Stefanos Zenios
  • Date: 2005-02-01
  • Publication Type: Cases
Miniature of Merck's Us. Managed Distribution Program for the HIV Drug Crixivan
Merck's Us. Managed Distribution Program for the HIV Drug Crixivan
  • GSB Authors: Margaret Eaton
  • Date: 2004-04-01
  • Publication Type: Cases
Miniature of Note on AIDS and the Pharmaceutical Industry
Note on AIDS and the Pharmaceutical Industry
  • GSB Authors: David Baron
  • Date: 2003-08-07
  • Publication Type: Cases
Miniature of GlaxoSmithKline and AIDS Drugs Policy
GlaxoSmithKline and AIDS Drugs Policy
  • GSB Authors: David Baron
  • Date: 2003-08-07
  • Publication Type: Cases
Miniature of Anglo American (A)
Anglo American (A)
  • GSB Authors: Joel M. Podolny
  • Date: 2002-02-01
  • Publication Type: Cases
Miniature of Pharmaceutical Switching
Pharmaceutical Switching
  • GSB Authors: David Baron
  • Date: 2001-08-01
  • Publication Type: Cases
Active filters
Keywords: pharmaceuticals   Remove all  

6 health care 5 pharmaceuticals industry 5 strategic planning 4 emerging markets 4 ethics and social responsibility 4 human resource management / organisational behaviour 4 production and operations management 4 public relations 3 AIDS 3 economics 3 economics, politics and business environment 3 ethics 3 government policy 3 growth strategy 3 marketing strategy 3 mergers and acquisitions (M&A) 3 politics and business environment 3 strategy and general management 2 business processes 2 corporate strategy 2 entrepreneurship 2 global business 2 innovation 2 market positioning 2 marketing planning 2 medical devices 2 negotiations 2 non-market 2 partnerships 2 product introduction 2 product life cycle 2 product management 2 public policy 2 tradeoff analysis 1 Africa 1 COVID 1 South Africa 1 World Trade Organisation (WTO) 1 advertising campaign 1 advertising ethics 1 biotechnology 1 clinical trials 1 compulsory licensing 1 consultants 1 cost effectiveness 1 cross-country analysis 1 cultural clashes 1 decision making 1 development stage enterprises 1 diffusion 1 direct-to-consumer 1 distribution 1 distribution channels 1 distribution planning 1 drugs 1 econometrics 1 economic policy 1 empirical industrial organization 1 employee benefits 1 employee empowerment 1 fiscal policy 1 government and business 1 health 1 health care systems 1 health services 1 hierarchical bayes 1 innovator 1 intellectual property 1 international operations 1 leadership 1 legal aspects of business 1 legal issues 1 management of change 1 management of crises 1 market research 1 marketing campaigns 1 medical device 1 medical supplies 1 national security 1 new product marketing 1 non-market factors 1 nonmarket issues 1 patents 1 payer 1 philanthropy 1 plant management 1 political economics 1 pricing strategy 1 product development 1 provider 1 public-private partnerships 1 reimbursement 1 reimbursement systems 1 restructuring 1 risk management 1 social change 1 social issues 1 strategic alliances 1 strategy 1 vaccine 1 world economy